Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transcriptional Profiles of CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin

10 Feb 2010

Abstract excerpt

Glioblastoma multiforme (GBM) is paradigmatic for the investigation of cancer stem cells (CSC) in solid tumors. Growing evidence suggests that different types of CSC lead to the formation of GBM. This has prompted the present comparison of gene expression profiles between 17 GBM CSC lines and their different putative founder cells. Using a newly derived 24-gene signature, we can now distinguish two subgroups of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer-related molecular mechanisms research
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20145155
DOI: 10.1158/0008-5472.can-09-1707

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transcriptional Profiles of CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of OriginPMID 20145155Read ↗

Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.Semantic proximity Read ↗

Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiformeSemantic proximity Read ↗

A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutationsSemantic proximity Read ↗

CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular ProfilesSemantic proximity Read ↗

Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapiesSemantic proximity Read ↗

Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin‐1 expressionSemantic proximity Read ↗

Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue.Semantic proximity Read ↗

Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic TargetingSemantic proximity Read ↗

A mesenchymal glioma stem cell profile is related to clinical outcomeSemantic proximity Read ↗

Current Strategies for Identification of Glioma Stem Cells: Adequate or Unsatisfactory?Semantic proximity Read ↗

Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.Semantic proximity Read ↗

Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated SignatureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.